Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xilin Jing

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Life Medicine|January 20, 2026
Dual-modality theranostics probes: sintegrative strategies for precision management of oncologic malignanciesXilin Jing, Yutao Li, Yijing Zhang, et al.
Cancer Biology & Medicine|July 25, 2025
Organoid models in oncology: advancing precision cancer therapy and vaccine developmentYuxuan Xiao, Yutao Li, Xilin Jing, et al.
Medcomm|July 14, 2025
Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic TargetsYutao Li, Qingyun Liu, Xilin Jing, et al.
International Journal of Cancer|July 31, 2025
Theranostics targeting fibroblast activation protein in the pan-cancer fieldYutao Li, Xilin Jing, Qingyun Liu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Life Medicine|January 20, 2026
Dual-modality theranostics probes: sintegrative strategies for precision management of oncologic malignanciesXilin Jing, Yutao Li, Yijing Zhang, et al.
Cancer Biology & Medicine|July 25, 2025
Organoid models in oncology: advancing precision cancer therapy and vaccine developmentYuxuan Xiao, Yutao Li, Xilin Jing, et al.
Medcomm|July 14, 2025
Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic TargetsYutao Li, Qingyun Liu, Xilin Jing, et al.
International Journal of Cancer|July 31, 2025
Theranostics targeting fibroblast activation protein in the pan-cancer fieldYutao Li, Xilin Jing, Qingyun Liu, et al.
Pageof 1